9月18日 - ** XtalPi Holdings（2228.HK）股价大涨9.9%至7.58港元，有望创下自8月20日以来单日最大涨幅
** 股价创下自8月28日以来的最高水平；在恒生生物科技指数 .HSBIO 中涨幅居第二位，该指数当日上涨1.6%
** 这家在香港上市的药物与材料科学研发解决方案提供商表示，其子公司LCC Technologies已与利兰·斯坦福大学（Leland Stanford Junior University）董事会签署了一项药物发现合作协议 (link)
** 此次合作不局限于特定疾病，将整合斯坦福大学的疾病生物学研究与LCC Technologies的自动化及人工智能驱动的小分子发现平台，以加速新药研发——XtalPi
** 今年以来，该公司股价下跌19.7%，基准恒生指数 .HSI 下跌3.3%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.